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A B S T R A C T
Psoriatic patients, along with skin changes, frequently show various psychological changes such as depression, anxi-
ety and have overall lower quality of life. The aim of this study was to evaluate the quality of life in patients with psoria-
sis compared to other dermatological patients, as well as to investigate the differences between the two subgroups – type I
and type II psoriasis. A total of 94 dermatological patients were included. The patients were divided into two groups, the
first group made of psoriatic patients which was further divided into two subgroups, and the second, control group made
of patients with other skin diseases. DSQL quality of life questionnaire was used. The study showed that among psoria-
tic patients there was no significant difference in the quality of life, but there was a significant difference between the pso-
riasis type I and the control group, which could be explained by the strong influence of the disease on the quality of life in
psoriatic patients.
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Introduction
Psoriasis vulgaris is a mulftifactorial heterogenetical
disease1. The disease is marked with keratoses prolifera-
tion along with an abnormal keratoses differentiation
and inflamed infiltrates CD8 in the dermis and CD4+
and T-cells in the epidermis2,3. For a clinical expression of
the disease environmental factors are necessary – trigger
factors4. Prevalence of psoriasis in Europe is 3–5%, while
in Croatia it amounts to 1–1.5%5,6. In some ethnic minor-
ities the occurrence of psoriasis is quite low, while among
Australian Aboriginals and natives of the Southern Ame-
rica it is extremely rare7,8. Type I psoriasis has early ap-
pearances before 40, familial inheritance and correlation
with HLA antigens9. Type II psoriasis has late onset, af-
ter 40, weak correlation with HLA antigens and rare fa-
milial occurrences of disease10. A person suffering from
psoriasis is viewed as an integral structure of the mind
and body, psychical and somatic is combined and ob-
served in constant interrelationship, which includes pso-
riasis into skin diseases with influence of psychosomatic
factors11,12. Quality of life is a complex condition and is
composed of various aspects – those are, mainly: physical
functioning, psychological status, social relationships,
sexual functioning, everyday activities and economic sta-
tus. Psoriasis has a large impact on the life of the patient
resulting in common psychological and social reactions
in patients with psoriasis13,14.
The aim of the study is the evaluation of the group I
and II in their quality of life based on five aspects of the
quality of life, and how much does psoriasis affect the
quality of life in these dermatological patients. In addi-
tion, we have realized the connection of the quality of life
in patients with psoriasis compared with other dermato-
logical patients.
Subjects and Methods
The quality of life in dermatological patients, as well
as the comparison between the psoriatic patients and the
control group, was evaluated by a specific DSQL test that
consists of various assertions, and we used offered an-
swers, which gave insight into the level of skin condition,
personal choices, behavior, relationships in the environ-
ment and the psychical state of patients.
The total number of patients was 94, and the study
was undertaken at the Department of Dermatology and
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Venerology, University Hospital Mostar in collaboration
with University Hospital »Sestre Milosrdnice« in Zagreb.
In a group of 63 patients, 40 of them were diagnosed with
psoriasis type I and 23 with psoriasis type II. The control
group which was treated for other skin diseases at our
Department (dermatomycosis, urticaria, allergic contact
dermatitis, spinaliomas, basaliomas, dysplastic nevus,
onychomycosis and hypostatic ulcer) was made of 31 pa-
tients. The use of psychological instruments for both
groups of patients was done by a clinical psychologist,
and the clinical and the control group of patients filled
out the same questionnaires. To encompass the variables
thought relevant for the connection between the quality
of life and psoriatic patients, we applied the following in-
struments: list of general data, list of disease date and
dermatological quality of life test. In our study we used
DSQL the test of the life quality of dermatological pa-
tients and statistical analysis was done with the statisti-
cal program SPSS 12.
Results
In the undertaken study of 94 patients, 51 (54.3%)
were male and 43 (45.7%) were female. Statistical analy-
sis of data in the medical records was on the level of skin
conditions of psoriatic patients, with the mean for cases
of 1.80 and 1.03 for controls (Table 1).
In the test for independent samples the results sug-
gest that there was a statistically significant difference
between psoriatic patients and patients from the control
group. Statistically significant difference (p<0.001) was
on the level of skin condition, personal choices, behavior
and psychological well-being, and on the level environ-
mental relationships (p=0.001). In the psoriatic patients
the disease has statistically significant stronger effect on
the quality of life than is the case with the control group
of patients (Table 2).
In the comparison of the results of the quality of life
test among psoriatic patients type I and II, on the level of
skin conditions, personal choices, behavior, environmen-
tal relationships and psychological well-being, there was
no statistically significant difference (Table 3).
According to the results of the t-test for independent
samples there was no statistically significant difference
(p>0.05) in the quality of life in studied group (Table 4).
Disscusion
The quality of life in dermatological patients and
their psychologic well-being studied by modern analysis
and psychometric examinations did not give distinctive
results but it gave insight into how patients experience
their diseases and how it affects the quality of life in
psoriatic patients15. The characteristic skin changes that
substantially affect the appearance of the patient often
cause a creation of a different picture of themselves,
which may result in the existence of depression and anxi-
ety symptoms and may change the psychological status
of the patient. The patients cannot effectively pursue
their usual activities and hobbies, and the treatment
takes away a lot of time and energy which has a profound
effect on the quality of life. Psoriasis has an effect on the
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TABLE 1
DIFFERENCES IN PSORIASIS AND CONTROL GROUP IN DSQL TEST RESULT
DSQL Total number of patients X SD
DSQL skin condition Psoriasis 63 1.80 0.72
Control group 31 1.03 0.63
DSQL personal choices Psoriasis 63 1.59 0.97
Control group 31 0.64 0.59
DSQL behavior Psoriasis 63 1.13 0.93
Control group 31 0.43 0.47
DSQL relationships Psoriasis 63 0.93 0.88
Control group 31 0.33 0.43
DSQL psychological well-being Psoriasis 63 1.28 0.95
Control group 31 0.59 0.59
TABLE 2
STATISTICAL ANALYSIS OF T-TEST BEWEEN PSORIATIC PATIENTS AND THE CONTROL GROUP
t df p
DSQL skin condition 5.09 92 <0.001
DSQL personal choices 5.02 92 <0.001
DSQL behavior 4.00 92 <0.001
DSQL relationships 3.60 92 <0.001
DSQL psychological well-being 3.70 92 <0.001
life of the patient, just like all the common psychological
and social reactions. All of these psychological factors can
have a possible causative role in the emergence, as well
as in the course of the disease13.
Psoriatic patients can have a reduced quality of life,
similar or even worse than some other patients suffering
from chronic diseases, such as heart diseases and diabe-
tes. The worsening of the quality of life in dermatological
patients corresponds with some papers in which it has
been given reference to it; 40% of patients believe that
the quality of life is connected with the manifestation of
the skin symptoms16.
Newer studies showed the connection of skin cell ac-
tivity with psychological stress, emotional distress, social
support, loneliness and confidence17. The results of this
study suggest that psoriatic patients have significantly
increased chances for the expression of symptoms of de-
pression and significantly reduced quality of life in the
level of five aspects: skin conditions, personal choices, be-
havior, environmental relationships and psychological
well-being. The given results in comparison of personal
data between the clinical group and the control group do
not show statistically significant differences. Psoriasis
has an effect on the psychical state of the patient because
of visibility of the skin changes, therefore one can as-
sume proper attitude towards dermatological patients
only if one shows equal attention to the psychological
problems as to the physical ones. In the specific derma-
tological quality of life test the patients answered ques-
tions about all five aspects of the quality and gave us in-
sight into the effect of the disease on the skin condition,
personal choices, behavior, environmental relationships
and psychological state of patients. In our research the
middle number of points of the test did not show any sig-
nificantly statistical difference in all patients, as well as
the groups of psoriasis type I and type II.
Statistical analysis between the psoriatic patients and
the group suffering from other skin diseases showed stati-
stically significant difference p<0.001 on all levels, and
in DSQL environmental relationships measured p=0.001.
In psoriatic patients we proved significantly stronger in-
fluence on the quality of life than is the case with other
skin diseases. The psychological aspects depend on the
subjective experience of the course of the disease and the
perception of one’s body and self-confidence. The dis-
torted self-perception and lowered self-esteem can result
in the emergence of symptoms of depression, anxiety, ob-
sessive compulsive disorders, which again result in the
reduced quality of life. Finally, the quality of life in the
clinical group in this research was significantly lowered
in comparison with the control group, which means that
the disease has significant influence on lowering the
quality of life in psoriatic patients.
Previous studies have shown that the clinical test re-
sult is not always a good indicator of the effect of the
diseases on the quality of life and the psychological
well-being of the patient18,19. There is a statistically sig-
nificant difference between the group suffering from
psoriasis and the control group, which is statistically
confirmed by significantly stronger disease effect on the
quality of life of the patients who are suffering from pso-
riasis. DSQL test has shown that there is no statistically
significant difference between patients diagnosed with
psoriasis type I and those with psoriasis type II. The re-
sults of this research indicate that there is a need for co-
operation of dermatologists, psychologists and psychia-
trists, considering that the psychological approach of
the treatment, like a supplement of the medical treat-
ment of psoriatic patients can improve the treatment
and the course of the disease, and therefore the quality
of life of the patient20.
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TABLE 3
DSQL-TEST BETWEEN PSORIASIS TYPE I AND TYPE II
Number of patients X SD
DSQL skin condition psoriasis type I 40 1.71 0.70
psoriasis type II 23 1.95 0.74
DSQL personal choices psoriasis type I 40 1.64 1.04
psoriasis type II 23 1.51 0.86
DSQL behavior psoriasis type I 40 1.10 0.97
psoriasis type II 23 1.19 0.86
DSQL relationships psoriasis type I 40 0.96 0.96
psoriasis type II 23 0.88 0.72
DSQL psychological well-being psoriasis type I 40 1.30 1.04
psoriasis type II 23 1.24 0.80
TABLE 4
STATISTICAL ANALYSIS OF PSORIASIS TYPE I AND TYPE II
WITH T-TEST
t df p
DSQL skin condition –1.24 61 0.221
DSQL personal choices 0.50 61 0.622
DSQL behavior –0.35 61 0.731
DSQL relationships 0.34 61 0.735
DSQL psychological well-being 0.26 61 0.795
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KVALITETA @IVOTA OBOLJELIH OD PSORIJAZE I RAZLIKA U KVALITETI @IVOTA IZME\U
PSORIJAZE TIP I I TIP II
S A @ E T A K
Bolesnici oboljeli od psorijaze,~esto uz promjene na ko`i, pokazuju i zna~ajne psiholo{ke promjene kao, depresiju,
anksioznost i smanjenu kvalitetu `ivota. Studija je obuhvatila 94 dermatolo{ka bolesnika. Ispitanici su podijeljeni u
dvije skupine, prva skupina oboljeli od psorijaze koji su podijeljeni u dvije podskupine, i kontrolna skupina druge der-
matoze. U studiji smo koristili test kvalitete `ivota DSQL dermatolo{kih bolesnika. Statisti~ka analiza napravljena je u
klinici za ko`ne i spolne bolesti Sestre milosrdnice Zagreb pomo}u statisti~kog programa SPSS 12.0. Cilj ovog istra`i-
vanja bio je ispitati kvalitetu `ivota psorijati~nih bolesnika u odnosu na druge dermatolo{ke bolesnike, kao i razliku
izme|u dvije podskupine tip I i tip II psorijati~nih bolesnika. Istra`ivanje je pokazalo kod bolesnika s psorijazom nema
statisti~ki zna~ajne razlike u testu kvalitete `ivota, ali postoji statisti~ki signifikantna razlika izme|u skupine s psorija-
zom i kontrolne skupine, {to obja{njava sna`an utjecaj bolesti na kvalitetu `ivota bolesnika s psorijazom.
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